She was ultimately diagnosed with gastroparesis by a gastroenterologist
GLP-1 receptor agonists, such as once-weekly semaglutide, liraglutide, exenatide and dulaglutide, have been shown to have high efficacy in terms of glycemic control, and are associated with weight loss and low risk of hypoglycemia [6]
The condition can cause severe and deadly complications, including: Breathing problems Infection Kidney failure Malnutrition Pancreatic cancer Pseudocyst (fluid and debris build-up in a pocket of the pancreas that can rupture, causing internal bleeding and infection) Lawsuits allege that people taking GLP-1 RAs like tirzepatide may be at risk of developing necrotizing pancreatitis
To minimise these effects, follow the prescribed dose titration schedule, eat smaller meals, avoid high-fat or spicy foods, and stay well-hydrated
Nije za ljudsku ili ivotinjsku upotrebu